A tagatose-4-epimerase mutant, its immobilized enzyme, preparation method, and application in D-tagatose synthesis.

By performing site-directed mutagenesis and immobilization on tagatose-4-epimerase, the TpT4E_V2 mutant was obtained, which solved the problem of low enzyme activity in the wild type and achieved efficient conversion of D-fructose to D-tagatose, making it suitable for industrial production.

CN123107980APending Publication Date: 2026-11-17HUANGSHAN ENILUO HEALTH TECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611383806.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-08
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

In existing technologies, the activity of wild-type tagatose-4-epimerase in catalyzing the conversion of D-fructose to D-tagatose is low, which is difficult to meet the needs of industrial production. Furthermore, the D-galactose isomerization method is limited by cost and unstable supply.

Method used

By site-directed mutagenesis of tagatose-4-epimerase, the mutant TpT4E_V2 was obtained and prepared as an immobilized enzyme. The enzyme was activated by Ni2+ and the reaction conditions were controlled to carry out the enzyme-catalyzed reaction.

Benefits of technology

The enzyme activity of the tagatose-4-epimerase mutant TpT4E_V2 was increased by about 2.5 times, and the immobilized enzyme maintained a relative enzyme activity of 72.6% after continuous use, which significantly improved the conversion rate and stability of D-fructose to D-tagatose.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123107980A_ABST
    Figure CN123107980A_ABST
Patent Text Reader

Abstract

This invention discloses a tagatose-4-epimerase mutant, its encoding gene, a recombinant vector constructed from the encoding gene, recombinant microorganisms obtained by transforming the recombinant vector, and the immobilized enzyme prepared from it, as well as its application in D-tagatose synthesis. This invention also discloses a method for preparing the immobilized enzyme and its application in D-tagatose synthesis. The tagatose-4-epimerase mutant TpT4E_V2 provided by this invention is suitable for both free enzyme catalytic systems and continuous application systems of immobilized enzymes. The tagatose-4-epimerase mutant TpT4E_V2 and its immobilized enzyme significantly improve the catalytic efficiency and process economy of D-fructose isomerization synthesis of D-tagatose, providing a feasible catalytic scheme for the green biomanufacturing of D-tagatose and showing good application prospects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of enzymatic catalytic synthesis technology, specifically to a tagatose-4-epimerase mutant, its immobilized enzyme, preparation method, and its application in D-tagatose synthesis. Background Technology

[0002] D-Tag sugar is a healthy sugar substitute with multiple functional properties and broad commercial application prospects. It is extremely low in calories, has a sweetness approximately 90% that of sucrose, and a taste very similar to sucrose, making it an ideal sucrose substitute. Furthermore, D-Tag sugar also possesses physiological functions such as preventing obesity, lowering blood sugar, preventing tooth decay, and acting as a prebiotic, making it of significant application value in the food, health product, and pharmaceutical manufacturing industries.

[0003] Enzymatic synthesis of D-tagatose has become a research hotspot in this field, with one-step isomerization being a crucial production process. For example, L-arabinose isomerase can catalyze the isomerization of D-galactose to D-tagatose, but this method is limited by the high price and unstable supply of D-galactose, making it difficult to meet the demands of industrial production. In contrast, using D-fructose as a substrate offers advantages in industrial application due to its wide availability, stable supply, and lower production costs.

[0004] Wild-type tagatose-4-epimerase can catalyze the conversion of D-fructose to D-tagatose. However, the activity of wild-type tagatose-4-epimerase in catalyzing the conversion of D-fructose to D-tagatose is generally low. Further modification and screening are needed to obtain tagatose-4-epimerase mutants with good catalytic performance and stability, thereby promoting the industrial application of D-fructose to D-tagatose synthesis. Summary of the Invention

[0005] This invention provides a tagatose-4-epimerase mutant, its immobilized enzyme, preparation method, and application in D-tagatose synthesis, to overcome the shortcomings of the prior art.

[0006] To achieve the above objectives, the present invention adopts the following technical solution:

[0007] The first aspect of this invention provides a tagatose-4-epimerase mutant, which is the tagatose-4-epimerase mutant TpT4E_V2;

[0008] The tagatose-4-epimerase mutant TpT4E_V2 is obtained by mutating glycine at position 99 to proline, proline at position 112 to lysine, and phenylalanine at position 238 to isoleucine in wild-type tagatose-4-epimerase TpT4E; the amino acid sequence of wild-type tagatose-4-epimerase TpT4E is shown in SEQ ID NO:1.

[0009] A second aspect of the present invention provides the gene for the above-mentioned tagatose-4-epimerase mutant.

[0010] A third aspect of the present invention provides a recombinant vector constructed from the encoding gene of the above-mentioned tagatose-4-epimerase mutant.

[0011] The fourth aspect of the present invention provides recombinant microorganisms obtained by transformation of the above-described recombinant vector.

[0012] The fifth aspect of this invention provides the application of the above-mentioned tagatose-4-epimerase mutant in the catalytic synthesis of D-tagatose from D-fructose. In application, the tagatose-4-epimerase mutant is used as a catalyst, and D-fructose is used as a substrate, in Ni... 2+ Under controlled conditions, temperature and stirring speed are controlled to carry out an enzyme-catalyzed reaction in the reaction medium to generate D-tagatose.

[0013] Furthermore, the reaction medium was 50-200 mM EPPS buffer, pH 7.3-8.7, the final concentration of tagatose-4-epimerase mutant was 0.5-5 mg / mL, the final concentration of D-fructose was 50-300 mg / mL, and Ni... 2+ The reaction was carried out using NiCl2 with a final concentration of 1-5 mM, at a controlled temperature of 50-70°C, with a stirring speed of 100-300 rpm and a reaction time of 1-5 h.

[0014] The sixth aspect of the present invention provides an immobilized enzyme prepared from the above-mentioned tagatose-4-epimerase mutant.

[0015] Further, the immobilized enzyme is prepared by the following steps: using 50-200 mM EPPS buffer, pH 7.3-8.7 as solvent, the tagatose-4-epimerase mutant and amino resin are added, the mass ratio of the tagatose-4-epimerase mutant to the amino resin is 10-100 mg:1 g, the amino resin includes LX-1000NH amino resin, and 1% (v / v)-5% (v / v) glutaraldehyde and 1% (v / v)-5% (v / v) polyethyleneimine are added, the glutaraldehyde is calculated as 50% (wt) glutaraldehyde, the polyethyleneimine is liquid with a purity ≥99% (wt), the immobilization temperature is 4-10℃, the stirring speed is 20-100 rpm, the immobilization time is 2-5 h, and the enzyme is filtered and washed to obtain the immobilized enzyme.

[0016] The seventh aspect of this invention provides the application of the above-mentioned immobilized enzyme in the catalytic synthesis of D-tagatose from D-fructose. In application, the immobilized enzyme is used as a catalyst, and D-fructose is used as a substrate in Ni... 2+Under controlled conditions, temperature and stirring speed are controlled to carry out an enzyme-catalyzed reaction in the reaction medium to generate D-tagatose.

[0017] Furthermore, the reaction medium was 50-200 mM EPPS buffer, pH 7.3-8.7, with a final immobilized enzyme concentration of 50-100 mg / mL, a final D-fructose concentration of 50-300 mg / mL, and Ni... 2+ The reaction was carried out using NiCl2 with a final concentration of 1-5 mM, at a controlled temperature of 50-70°C, with a stirring speed of 100-300 rpm and a reaction time of 1-5 h.

[0018] The beneficial effects of this invention are:

[0019] This invention obtains the tagatose-4-epimerase mutant TpT4E_V2 by site-directed mutagenesis of wild-type tagatose-4-epimerase TpT4E, which is suitable for both free enzyme catalytic systems and continuous application systems of immobilized enzymes.

[0020] Compared to the wild-type tagatose-4-epimerase TpT4E, the tagatose-4-epimerase mutant TpT4E_V2 exhibited an activity increase of approximately 2.5-fold. Under a substrate condition of 300 mg / mL D-fructose, the free tagatose-4-epimerase mutant TpT4E_V2 achieved a 26.8% conversion rate of D-fructose to D-tagatose within 4 h, significantly higher than that of the free wild-type tagatose-4-epimerase TpT4E (13.8%).

[0021] Further preparation of the tagatose-4-epimerase mutant TpT4E_V2 into an amino resin immobilized enzyme resulted in a 25.1% conversion rate of D-fructose to D-tagatose within 4 h, approximately 2.1 times that of the wild-type tagatose-4-epimerase TpT4E immobilized enzyme. More importantly, the tagatose-4-epimerase TpT4E_V2 immobilized enzyme maintained 72.6% relative enzyme activity after 30 consecutive applications (compared to only 22.1% relative enzyme activity for the wild-type tagatose-4-epimerase TpT4E immobilized enzyme after 30 applications), demonstrating excellent operational stability and reusability. The tagatose-4-epimerase mutant TpT4E_V2 and its immobilized enzyme provided by this invention significantly improve the catalytic efficiency and process economy of D-fructose isomerization synthesis of D-tagatose, providing a feasible catalytic scheme for the green biomanufacturing of D-tagatose and showing good application prospects. Attached Figure Description

[0022] Figure 1The results of SDS-PAGE analysis of tagatose-4-epimerase TpT4E and its mutants in Example 3 are shown.

[0023] Figure 2 The results of SDS-PAGE analysis of tagatose-4-epimerase TaT4E and its mutants in Example 3 are shown.

[0024] Figure 3 The results of SDS-PAGE analysis of tagatose-4-epimerase CbT4E and its mutants in Example 3 are shown.

[0025] Figure 4 The results show the effects of different metal ions on the activity of tagatose-4-epimerase.

[0026] Figure 5 The conversion rates of D-tagastrose to D-tagastrose catalyzed by tagatose-4-epimerase and mutants are compared.

[0027] Figure 6 The results show the conversion rates of D-fructose to D-tagatose catalyzed by different immobilized enzymes.

[0028] Figure 7 The results of relative enzyme activity determination for different immobilized enzymes after 30 cycles. Detailed Implementation

[0029] The present invention will be further explained below with reference to the embodiments and accompanying drawings. The following embodiments are for illustrative purposes only and are not intended to limit the scope of the invention.

[0030] Unless otherwise specified in the following implementation plan, the test conditions are generally as per standard test conditions or the test conditions recommended by the reagent company. Unless otherwise specified, all materials and reagents used are commercially available.

[0031] The culture medium formulations involved in the following examples are as follows:

[0032] SOC liquid medium (1 L): 20 g tryptone, 5 g yeast extract, 0.5 g sodium chloride, 10 mL 250 mM potassium chloride, 10 mL 1 M magnesium chloride, 10 mL 1 M magnesium sulfate, 5 mL 1 M D-glucose (added separately before use after sterilization by filtration through a 0.22 μm filter membrane); pH 7.2.

[0033] LB liquid medium (1 L): 10 g tryptone, 5 g yeast extract, 10 g sodium chloride; pH 7.0.

[0034] LB solid medium is made by adding 20 g of agar powder to 1 L of LB liquid medium.

[0035] All of the above culture media need to be autoclaved at 121°C for 20 min.

[0036] Example 1: Construction of recombinant Escherichia coli with tagatose-4-epimerase

[0037] I. Construction of Recombinant Plasmids

[0038] Drooping thermophyte ( Thermofilum pendens The gene fragment encoding the wild-type tagatose-4-epimerase TpT4E in the genome of *Thermophyllus* (gene sequence as shown in SEQ ID NO: 2, amino acid sequence as shown in SEQ ID NO: 1) is from *Thermophyllus*. Thermofilum adornatum The gene fragment encoding the wild-type tagatose-4-epimerase TaT4E in the genome (gene sequence as shown in SEQ ID NO: 4, amino acid sequence as shown in SEQ ID NO: 3), deep archaea ( Candidatus Bathyarchaeia The gene fragment encoding wild-type tagatose-4-epimerase CbT4E in the genome (gene sequence as shown in SEQ ID NO: 6, amino acid sequence as shown in SEQ ID NO: 5) was synthesized by Sangon Biotech (Shanghai) Co., Ltd. after codon optimization of E. coli. The optimized gene fragment was then constructed into the vector pET-28a(+) to obtain recombinant plasmids.

[0039] II. Transformation of Escherichia coli with recombinant plasmids E. coli BL21(DE3)

[0040] The recombinant plasmid obtained in step one of Example 1 was transformed into the strain using a heat shock method. E. coli In BL21(DE3). The specific steps are as follows: 100 μL in each tube E. coli Add 10 μL of 1 ng / μL recombinant plasmid to a suspension of BL21(DE3) competent cells (OD approx. 0.4-0.6), mix gently, and incubate on ice for 30 min. Transfer to a 42°C water bath and heat shock for 90 s. Quickly transfer to an ice bath and cool for 3 min. Add 700 μL of antibiotic-free SOC liquid medium to each tube and incubate at 37°C and 100 rpm on a shaker for 40 min. After incubation, centrifuge the culture at 4°C and 12000 rpm for 10 min, discard 600 μL of supernatant, and spread the remaining culture onto a plate containing 50 μg / mL plasmid. -1 Incubate kanamycin sulfate on LB solid medium plates at 37°C inverted overnight.

[0041] Selection of positive clones: Four clones were selected and transferred to 5 mL of solution containing 50 μg / mL of solution. -1 The plasmid was cultured in LB liquid medium containing kanamycin sulfate at 37°C and 200 rpm for 8 h. Plasmids were extracted using the Mini-Plasmid Rapid Isolation Kit (Beijing Bodatech Biotechnology Co., Ltd.). 20 μL of plasmid was then sent to Sangon Biotech (Shanghai) Co., Ltd., where DNA sequencing confirmed successful construction.

[0042] Example 2 Construction of recombinant Escherichia coli with tagatose-4-epimerase mutant

[0043] I. Construction of Recombinant Plasmids

[0044] The sequence of wild-type tagatose-4-epimerase in step one of Example 1 was analyzed, and multiple mutants were designed using bioinformatics methods, as shown in Table 1.

[0045] Table 1

[0046]

[0047] TpT4E_V1 is a wild-type tagatose-4-epimerase TpT4E with a serine mutation at position 96 (valine), a proline mutation at position 112 (lysine), and a phenylalanine mutation at position 238 (isoleucine).

[0048] TpT4E_V2 is a wild-type tagagose-4-epimerase TpT4E with a mutation at position 99 (glycine to proline), position 112 (proline to lysine), and position 238 (phenylalanine to isoleucine).

[0049] TaT4E_V1 is a wild-type tagatose-4-epimerase TaT4E with a 47th lysine mutated to glutamic acid and a 314th asparagine mutated to histidine.

[0050] TaT4E_V2 is a wild-type tagatose-4-epimerase TaT4E with a 47th lysine mutated to glutamic acid, a 244th phenylalanine mutated to serine, and a 314th asparagine mutated to histidine.

[0051] CbT4E_V1 is a wild-type tagatose-4-epimerase CbT4E with a mutation at position 34 (glycine to asparagine), position 270 (lysine to arginine), and position 309 (tryptophan to tyrosine).

[0052] CbT4E_V2 is a wild-type tagatose-4-epimerase CbT4E with a mutation at position 34 (glycine to histidine), position 270 (lysine to arginine), and position 309 (tryptophan to tyrosine).

[0053] All the mutants were codon optimized by Sangon Biotech (Shanghai) Co., Ltd., and the optimized gene fragments were synthesized and constructed into the vector pET-28a(+) to obtain recombinant plasmids.

[0054] II. Transformation of Escherichia coli with recombinant plasmids E. coli BL21(DE3)

[0055] The recombinant plasmid obtained in step one of Example 2 was transformed into the strain using a heat shock method. E. coli In BL21(DE3). The specific steps are as follows: 100 μL in each tube E. coli Add 10 μL of 1 ng / μL recombinant plasmid to a suspension of BL21(DE3) competent cells (OD approx. 0.4-0.6), mix gently, and incubate on ice for 30 min. Transfer to a 42°C water bath and heat shock for 90 s. Quickly transfer to an ice bath and cool for 3 min. Add 700 μL of antibiotic-free SOC liquid medium to each tube and incubate at 37°C and 100 rpm on a shaker for 40 min. After incubation, centrifuge the bacterial culture at 4°C and 12000 rpm for 10 min, discard 600 μL of supernatant, and spread the remaining bacterial culture onto LB agar plates containing 50 μg / mL kanamycin sulfate. Incubate overnight at 37°C with the plates inverted.

[0056] Selection of positive clones: Four clones were selected and transferred to 5 mL of LB liquid medium containing 50 μg / mL kanamycin sulfate. The cultures were incubated at 37°C and 200 rpm for 8 h. Plasmids were extracted using the Mini-Plasmid Rapid Isolation Kit (Beijing Bodatech Biotechnology Co., Ltd.). 20 μL of plasmid was taken and sent to Sangon Biotech (Shanghai) Co., Ltd., where DNA sequencing confirmed successful construction.

[0057] Example 3: Induced expression culture of recombinant Escherichia coli

[0058] The recombinant *E. coli* strains constructed in Examples 1 and 2, as well as the recombinant *E. coli* strain from the control group (pET-28a(+) empty vector transformant, as a negative control), were inoculated into 10 mL of LB broth containing 50 μg / mL kanamycin sulfate and cultured overnight at 37°C with shaking at 200 rpm. 10 mL of the culture was then transferred to 1 L of LB broth containing 50 μg / mL kanamycin sulfate. -1In LB broth containing kanamycin sulfate, the culture was carried out at 37°C with shaking at 200 rpm until OD reached. 600 The concentration was approximately 0.6-0.8. Isopropyl-β-D-thiogalactoside (IPTG) was added to the culture to a final concentration of 0.5 mM, and the culture was induced at 28°C and 200 rpm for 12 h. The culture medium was centrifuged at 4°C and 12000 rpm for 10 min, the supernatant was discarded, and the precipitate (bacterial cells) was collected. The bacterial cells were dispersed in 14 mL of 100 mM EPPS buffer (pH 7.5) and sonicated in an ice bath. The sonication parameters were as follows: the ultrasonic power of the ultrasonic cell disruptor (purchased from Ningbo Xinzhi Biotechnology Co., Ltd., model JY92-IIN) was set to 10%, and the sonication time was 30 min (2 s working time, 3 s interval). A portion of the sonicated bacterial cells (i.e., whole cell lysate) was used for SDS-PAGE analysis, and the other portion was centrifuged at 4°C and 12000 rpm for 10 min. The supernatant and precipitate were then used for SDS-PAGE analysis separately. Figures 1-3 As shown, the SDS-PAGE results indicate that the soluble expression levels of each target protein are high and the molecular weights are correct.

[0059] Example 4 Purification of recombinant protein

[0060] The recombinant *E. coli* strains constructed in Examples 1 and 2 were inoculated into 50 mL of LB liquid medium containing 50 μg / mL kanamycin sulfate and cultured overnight at 37°C with shaking at 200 rpm. 50 mL of the culture was then transferred to 5 L of LB liquid medium containing 50 μg / mL kanamycin sulfate and cultured at 37°C with shaking at 200 rpm until OD (dose eluent) was reached. 600 The concentration is approximately 0.6-0.8. IPTG was added to the culture to a final concentration of 0.5 mM, and the culture was induced at 28℃ and 200 rpm for 12 h. The culture solution was centrifuged at 4℃ and 12000 rpm for 10 min, the supernatant was discarded, and the precipitate (bacterial cells) was collected. The bacterial cells were washed three times with physiological saline to obtain wet bacterial cells.

[0061] Weigh 20 g of wet bacterial cells and suspend them in 70 mL of 100 mM EPPS buffer (pH 7.5). Sonicate the cells in an ice bath. The sonication parameters were: 10% ultrasonic power and 30 min sonication time (2 s working time, 3 s interval). Centrifuge the sonicated cells at 4°C and 12000 rpm for 10 min, and collect the supernatant as the crude enzyme solution. Purify the crude enzyme solution using a His-Trap HP affinity column. After ultrafiltration and desalting, concentrate the solution using a 30 KD ultrafiltration tube at 4°C and 6000 rpm for 30 min to obtain a 5 mg / mL pure enzyme solution. Store the obtained pure enzyme solutions (5 mg / mL) of tagatose-4-epimerase and its mutants at 4°C for later use. The pure enzyme solutions required in the following examples are provided in this example; if some pure enzyme solutions are insufficient, scale up the process accordingly.

[0062] Example 5: Determination of D-fructose and D-tagatose content by HPLC

[0063] Sample preparation method: Dissolve and dilute the sample with ultrapure water until the D-fructose or D-tagatose content is about 1-20 mg / mL, filter it through a 0.22 μm aqueous filter membrane and then inject it for detection.

[0064] HPLC detection method: An Agilent 1260 Infinity HPLC system with a differential refractive index detector was used. The chromatographic column was Sepax Carbomix Ca-NP5:8% (7.8×300 mm, 5 μm). The mobile phase was pure water. The column temperature was 80℃, the flow rate was 0.6 mL / min, the detector temperature was 35℃, and the run time was 16 min.

[0065] Example 6 Effect of metal ions on the activity of tagatose-4-epimerase

[0066] To investigate the effect of metal ions on the activity of tagatose-4-epimerase, Ca2+ was added to the reaction system at a final concentration of 2 mM. 2+ Co 2+ Ni 2+ Mn 2+ and Mg 2+A reaction system without added metal ions was used as a control. The total volume of the reaction system was 10 mL, and the solvent was 100 mM EPPS buffer (pH 7.5), containing a final concentration of 100 mg / mL D-fructose and 800 μL of pure enzyme solution of 5 mg / mL tagatose-4-epimerase prepared in Example 4. After reacting at 60 °C and 200 rpm for 1 h, 0.3 mL of 10% (v / v) sulfuric acid solution was added to terminate the reaction. The content of D-tagatose in the reaction solution was detected by HPLC according to the method described in Example 5. The relative enzyme activity under the action of each metal ion was calculated with the highest enzyme activity under the test conditions as 100%, and the results are as follows. Figure 4 As shown. The reactions catalyzed by tagatose-4-epimers TpT4E, TaT4E, and CbT4E for the isomerization of D-fructose to D-tagatose all depend on the activation of metal ions, among which Ni... 2+ The activation effect is the strongest among the three enzymes in Ni 2+ The relative enzyme activity in the presence of these metal ions was significantly higher than that in the other metal ion groups and the control group.

[0067] Example 7 Enzyme activity assay of tagatose-4-epimerase and its mutants

[0068] Enzyme activity assay conditions: The total reaction volume was 10 mL, the solvent was 100 mM EPPS buffer (pH 7.5), including a final concentration of 100 mg / mL D-fructose, a final concentration of 2 mM NiCl2, and 800 μL of pure enzyme solution of 5 mg / mL tagatose-4-epimerase or its mutant prepared in Example 4. The reaction was carried out at 60°C and 200 rpm for 1 h, and then 0.3 mL of 10% (v / v) sulfuric acid solution was added to terminate the reaction. The D-tagatose content in the reaction solution was detected by HPLC according to the method in Example 5. Enzyme activity was defined as the amount of enzyme required to catalyze the production of 1 μmol of D-tagatose per minute under the above assay conditions.

[0069] The enzyme activity test results of tagatose-4-epimerase and its mutants are shown in Table 2.

[0070] Table 2

[0071]

[0072] The results above show that, compared to the wild-type tagatose-4-epimers, the mutants constructed in Example 2 all exhibited higher enzyme activities under the assay conditions. Specifically, the activities of wild-type tagatose-4-epimers TpT4E and TaT4E were 0.85 and 0.77 U / mg, respectively, significantly higher than that of wild-type CbT4E (0.23 U / mg). The activity of the tagatose-4-epimer mutant TpT4E_V2 was 2.13 U / mg, approximately 2.5 times that of the wild-type tagatose-4-epimer TpT4E (0.85 U / mg).

[0073] Example 8: Tagatose-4-epimerase and its mutants catalyze the synthesis of D-tagatose from D-fructose.

[0074] The tagatose-4-epimerase and its mutant obtained in Example 4 were used for the synthesis of D-tagatose. The total volume of the reaction system was 10 mL, and the solvent was 100 mM EPPS buffer (pH 7.5), including a final concentration of 2 mM NiCl2, a final concentration of 2 mg / mL tagatose-4-epimerase or its mutant (prepared in Example 4), and D-fructose substrate with final concentrations of 100 mg / mL or 300 mg / mL, respectively. The reaction was carried out at 60 °C and 200 rpm for 4 h. After the reaction was completed, 0.3 mL of 10% (v / v) sulfuric acid solution was added to terminate the reaction. Following the method in Example 5, the contents of D-fructose and D-tagatose in the reaction solution were detected by HPLC, and the conversion rate of D-fructose to D-tagatose was calculated. The conversion rate was calculated as follows: Conversion rate (%) = Amount of D-tagatose actually generated / Amount of initial D-fructose × 100%.

[0075] The results are as follows Figure 5 As shown, under the experimental conditions, the conversion rates of each tagatose-4-epimerase mutant were higher than those of their corresponding wild-type tagatose-4-epimerases. When the D-fructose concentration was 300 mg / mL, the tagatose-4-epimerase mutant TpT4E_V2 exhibited the highest conversion rate at 26.8%, while the wild-type tagatose-4-epimerase TpT4E only achieved 13.8%.

[0076] Example 9 Preparation of tagatose-4-epimerase and its mutant immobilized enzyme

[0077] The total volume of the immobilization reaction system was 20 mL, and the solvent was 100 mM EPPS buffer (pH 7.5). It included 6 mL of tagatose-4-epimerase (TpT4E, TaT4E) or its mutants (TpT4E_V1, TpT4E_V2, TaT4E_V1, TaT4E_V2) obtained in Example 4 (5 mg / mL), 1 g LX-1000NH amino resin (Xi'an Lanxiao Technology New Materials Co., Ltd., resin not included in the total system volume), 0.5 mL glutaraldehyde (50% (wt) aqueous solution, MACKLIN, catalog number G810413), and 0.2 mL polyethyleneimine (purity ≥99% (wt), Aladdin, catalog number E107079). The mixture was stirred at 10°C and 50 rpm for 5 h, then filtered to obtain a solid. The solid was then subjected to 100... Wash with mL of deionized water and filter to obtain tagatose-4-epimerase or its mutant immobilized enzyme.

[0078] Example 10: Tragase-4-epimerase and its mutant immobilized enzyme catalyze the synthesis of D-tagatose from D-fructose.

[0079] The prepared tagatose-4-epimerase or its mutant immobilized enzyme was used for the synthesis of D-tagatose. The total volume of the reaction system was 10 mL, and the solvent was 100 mM EPPS buffer (pH 7.5), including a final concentration of 300 mg / mL D-fructose, a final concentration of 2 mM NiCl2, and 1 g of the tagatose-4-epimerase or its mutant immobilized enzyme prepared in Example 9 (the immobilized enzyme was not included in the total volume of the reaction system). The reaction was carried out at 60 °C and 200 rpm for 4 h. After the reaction, the immobilized enzyme was immediately separated by filtration. Following the method described in Example 5, the contents of D-fructose and D-tagatose in the reaction solution were detected by HPLC, and the conversion rate of D-fructose to D-tagatose was calculated. The conversion rate was calculated as follows: Conversion rate (%) = Amount of D-tagatose actually generated / Amount of initial D-fructose × 100%.

[0080] The results are as follows Figure 6 As shown, the catalytic performance of each tagatose-4-epimerase mutant immobilized enzyme is superior to that of the corresponding wild-type tagatose-4-epimerase immobilized enzyme. The tagatose-4-epimerase mutant TpT4E_V2 immobilized enzyme has the highest conversion rate, reaching 25.1%, which is approximately 2.1 times that of the tagatose-4-epimerase TpT4E immobilized enzyme (12.2%).

[0081] The filtered tagatose-4-epimerase TpT4E immobilized enzyme or tagatose-4-epimerase mutant TpT4E_V2 immobilized enzyme was washed with 10 mL of deionized water and filtered again, then reused in the reaction for a total of 30 cycles. The relative enzyme activity of each immobilized enzyme was calculated at different cycles (with the enzyme activity measured at the 0th cycle of each immobilized enzyme as 100%). The results are as follows: Figure 7 As shown, the immobilized enzyme of the tagatose-4-epimerase mutant TpT4E_V2 exhibits good operational stability, retaining 72.6% of the relative enzyme activity after 30 cycles of application, while the immobilized enzyme of the tagatose-4-epimerase TpT4E retains only 22.1% of the relative enzyme activity after 30 cycles of application.

Claims

1. A tagatose-4-epimerase mutant, characterized in that, It is a tagatose-4-epimerase mutant, TpT4E_V2; The tagatose-4-epimerase mutant TpT4E_V2 is obtained by mutating glycine at position 99 to proline, proline at position 112 to lysine, and phenylalanine at position 238 to isoleucine in wild-type tagatose-4-epimerase TpT4E; the amino acid sequence of wild-type tagatose-4-epimerase TpT4E is shown in SEQ ID NO:

1.

2. The gene encoding the tagatose-4-epimerase mutant of claim 1.

3. A recombinant vector constructed from the encoding gene of the tagatose-4-epimerase mutant as described in claim 2.

4. The recombinant microorganism obtained by transformation of the recombinant vector according to claim 3.

5. The application of the tagatose-4-epimerase mutant of claim 1 in the catalytic synthesis of D-tagatose from D-fructose, characterized in that, In application, the tagatose-4-epimerase mutant is used as a catalyst, and D-fructose is used as a substrate, in Ni 2+ Under controlled conditions, temperature and stirring speed are controlled to carry out an enzyme-catalyzed reaction in the reaction medium to generate D-tagatose.

6. The application according to claim 5, characterized in that, The reaction medium was 50-200 mM EPPS buffer, pH 7.3-8.

7. The final concentration of tagatose-4-epimerase mutant was 0.5-5 mg / mL, and the final concentration of D-fructose was 50-300 mg / mL. 2+ The reaction was carried out using NiCl2 with a final concentration of 1-5 mM, at a controlled temperature of 50-70°C, with a stirring speed of 100-300 rpm and a reaction time of 1-5 h.

7. The immobilized enzyme prepared from the tagatose-4-epimerase mutant of claim 1.

8. The immobilized enzyme according to claim 7, characterized in that, The immobilized enzyme is prepared by the following steps: using 50-200 mM EPPS buffer (pH 7.3-8.7) as solvent, the tagatose-4-epimerase mutant and amino resin are added, with a mass ratio of 10-100 mg:1 g, the amino resin including LX-1000NH amino resin, and 1% (v / v)-5% (v / v) glutaraldehyde and 1% (v / v)-5% (v / v) polyethyleneimine are added, the glutaraldehyde being calculated as 50% (wt) glutaraldehyde, the polyethyleneimine being a liquid with a purity ≥99% (wt), the immobilization temperature being 4-10℃, the stirring speed being 20-100 rpm, the immobilization time being 2-5 h, and the enzyme being filtered and washed to obtain the immobilized enzyme.

9. The application of the immobilized enzyme according to claim 7 or 8 in the catalytic synthesis of D-tagatose from D-fructose, characterized in that, In application, the immobilized enzyme is used as a catalyst, and D-fructose is used as a substrate, in Ni 2+ Under controlled conditions, temperature and stirring speed are controlled to carry out an enzyme-catalyzed reaction in the reaction medium to generate D-tagatose.

10. The application according to claim 9, characterized in that, The reaction medium was 50-200 mM EPPS buffer, pH 7.3-8.

7. The final concentration of the immobilized enzyme was 50-100 mg / mL, the final concentration of D-fructose was 50-300 mg / mL, and Ni... 2+ The reaction was carried out using NiCl2 with a final concentration of 1-5 mM, at a controlled temperature of 50-70°C, with a stirring speed of 100-300 rpm and a reaction time of 1-5 h.